Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.
Scope of the Report:
In the last several years, global market of Botulinum Toxins developed rapidly, with an average growth rate of 14.6%. In 2017, global revenue of Botulinum Toxins is nearly 4000 million USD; the actual production is about 12.4 million units.
The classification of Botulinum Toxins includes 50U, 100U and other, and the sales proportion of 50U in 2017 is about 59.3%. Botulinum Toxins is used for medical and cosmetic. Medical was the largest application segment in 2017, the proportion is about 51%.
The worldwide market for Botulinum Toxins is expected to grow at a CAGR of roughly 13.3 ...
Table of Contents
1 Market Overview
1.1 Botulinum Toxins Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
126.96.36.199 United States Market States and Outlook (2014-2024)
188.8.131.52 Canada Market States and Outlook (2014-2024)
184.108.40.206 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
220.127.116.11 Germany Market States and Outlook (2014-2024)
18.104.22.168 France Market States and Outlook (2014-2024)
22.214.171.124 UK Market States and Outlook (2014-2024)
126.96.36.199 Russia Market States and Outlook (2014-2024)
188.8.131.52 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast ...